Skip to main content
. 2016 Aug;138(2):482–490.e7. doi: 10.1016/j.jaci.2015.11.040

Table I.

Clinical assessment of genotyped subjects

WT non-AD WT AD FLG non-AD FLG AD
TEWL and tape-stripping group
 No. 18 46 8 12
 Age (y [range]) 28 (19-59) 35 (18-76) 28 (19-58) 35 (22-57)
 Male/female sex 8/10 16/30 4/4 5/7
 SASSAD ± SD NA 11 ± 9.3 NA 12 ± 7.5
 IgE ± SD (IU/mL) 63 ± 63 (n = 14) 678 ± 1374 (n = 46) 33 ± 47 (n = 6) 443 ± 892 (n = 12)
 Asthma 2 (11%) 15 (33%) 2 (25%) 5 (42%)
 Hay fever 1 (6%) 27 (59%) 1 (13%) 4 (33%)
Suction blister flow cytometry group
 No. 8 7 4 8
 Age (y [range]) 31 (20-55) 42 (27-76) 21 (19-25) 37 (27-57)
 Male/female sex 3/5 3/4 3/1 3/5
 SASSAD ± SD NA 6 ± 4 NA 8 ± 3
Suction blister immunostaining group
 No. 4 3 5 4
 Age (y [range]) 34 (21-51) 21 (20-21) 35 (20-54) 40 (22-56)
 Male/female sex 3/1 2/1 4/1 2/2
 SASSAD ± SD NA 12 ± 8 NA 15 ± 8

NA, Not applicable; SASSAD, Six-Area, Six-Sign Atopic Dermatitis score.

P = .0001, AD versus non-AD.

P = .0001, AD versus non-AD.